Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.66 USD | -0.93% | -0.47% | -32.67% |
May. 07 | MoonLake Immunotherapeutics Q1 Net Loss Widens | MT |
May. 07 | MoonLake Immunotherapeutics Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.56B |
---|---|---|---|---|---|
Net income 2024 * | -84M | Net income 2025 * | -107M | EV / Sales 2024 * | - |
Net cash position 2024 * | 462M | Net cash position 2025 * | 372M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-33.1
x | P/E ratio 2025 * |
-23
x | Employees | 50 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.73% |
1 day | -0.93% | ||
1 week | -0.47% | ||
1 month | -5.09% | ||
3 months | -20.15% | ||
6 months | -11.80% | ||
Current year | -32.67% |
Managers | Title | Age | Since |
---|---|---|---|
Jorge da Silva
FOU | Founder | 47 | 22-04-04 |
Kristian Reich
FOU | Founder | 58 | 22-04-04 |
Director of Finance/CFO | 36 | 22-04-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Sturge
CHM | Chairman | 65 | 22-04-04 |
Director/Board Member | 64 | 22-04-04 | |
Spike N. Loy
BRD | Director/Board Member | 43 | 22-04-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.23% | 4 M€ | -5.15% | - | |
1.06% | 5 M€ | +15.85% | ||
0.02% | 746 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 40.66 | -0.93% | 335,281 |
24-05-30 | 41.04 | -0.10% | 360,524 |
24-05-29 | 41.08 | -1.49% | 374,937 |
24-05-28 | 41.7 | +2.08% | 246,703 |
24-05-24 | 40.85 | +2.23% | 424,603 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.67% | 2.56B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- MLTX Stock